The CRISPR Technology Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The CRISPR technology global market has witnessed significant expansion in recent times. The market value, which was $2.05 billion in 2024, is projected to increase to $2.53 billion in 2025, demonstrating a Compound Annual Growth Rate (CAGR) of 23.7%.
The CRISPR technology market is predicted to expand significantly, reaching a value of $5.75 billion in 2029. This growth represents a compound annual growth rate (CAGR) of 22.7%.
Download Your Free Sample of the 2025 CRISPR Technology Market Report and Uncover Key Trends Now!The key drivers in the crispr technology market are:
• Rising demand for gene therapeutics
• Technological advancements in genome editing
• Increasing demand for drug discovery
• Rising adoption of CRISPR technologies in agriculture applications
The CRISPR technology market covered in this report is segmented –
1) By Product Type: Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products
2) By Application: Biomedical, Agriculture, Diagnostics, Other Applications
3) By End-User: Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs)
The key trends in the crispr technology market are:
• Development and innovation in next-generation CRISPR technologies are emerging trends.
• Improvements in CRISPR technologies for optimal results in new drug developments is a significant trend.
• Incorporation of AI to enhance the efficiency and precision of gene editing with CRISPR is an upcoming trend.
• Establishment of collaborations with companies and investments in novel approaches like IDMseq for better accuracy are also future trends.
Major companies in the crispr technology market are:
• Crispr Therapeutics
• Thermo Fisher Scientific
• Intellia Therapeutics
• Horizon Discovery
• Synthego Corporation
• Integrated Dna Technology (Danaher)
• Editas Medicine
• GenScript
• Agilent Technologies
• New England Biolabs
• CSIR-Institute of Genomics & Integrative Biology (IGIB)
• Strand Life Sciences Pvt. Ltd.
• Bio Palette Co. Ltd.
• CSL Limited
• C4U Co. Ltd.
• BGI Group
• Churchi Genome Engineering and Therapeutic Research Center.
• Beam Therapeutics Inc.
• Eurofins Genomics India
• Setsurotech Co. Ltd.
• Merck Japan
• Institut Pasteur
• CureVac
• Cellectis
• BiovelocITA S.r.l.
• Evotec A.G.
• SNIPR Biome
• Oxford Genetics
• ERS Genomics
• Alia Therapeutics
• Solvo
• BioTalentum
• Rosneft
• BIOCAD
• BioVendor, Research & Diagnostic Products
• Contipro
• Lonza Biotec
• Sotio
• Selvita
• BioVentures Institute Ltd
• Sigma-Aldrich
• Poseida Therapeutics
• NanoCellect Biomedical
• Sherlock Biosciences
• Repare Therapeutics
• Inscripta Inc.
• Santa Cruz Biotechnology
• Caribou Biosciences Inc.
• Egenesis Inc.
• Homology Medicines
• System Biosciences
• Takara Bio USA Inc.
• Inari Agriculture Inc.
• Precision BioSciences
• Cell Microsystems Inc.
• GeneCopoeia Inc.
• Horizon Discovery Group
• Merck KGaA
• Origene Technologies Inc.
• Pluristem Therapeutics Inc.
North America was the largest region in the CRISPR technology market in 2024